TiGenix (Spain)

TiGenix (Spain)

TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for TiGenix (Spain), Spain, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

73%


Total
Publications

171


Total Open
Publications

125


Total
Citations

4.4K


Open Access
Percentage

73%


Total
Publications

171


Total Open
Publications

125


Total
Citations

4.4K

Wikipedia

Website

download

Breakdown

30% 34% 9% 27%

Publisher Open

30%

Both

34%

Other Platform Open

9%

Closed

27%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

50

Hybrid 25%

28

No Guarantees 29%

32

Other Platform Open

Domain 64%

47

Institution 38%

28

Other Internet 23%

17

Public 22%

16

Preprint 12%

9

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
46
Europe PMC
Domain
32
Semantic Scholar
Public
13
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
8
Radboud University - Radboud Repository
Institution
4
Zenodo
Public
3
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB
Institution
3
Research Square
Preprint
3
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
3
Unknown Repository
Other Internet
2
1 / 5

Data updated 7 April 2025

Share

Share

Share